ReCode Therapeutics Competitors and Similar CompaniesClear all

ReCode Therapeutics's competitors and similar companies include Vertex Pharmaceuticals, BillionToOne, Synspira and PTC Therapeutics.

	ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.	Synspira Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases.	PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
Founding Date	Founding Date 2015	Founding Date 1989	Founding Date 2016	Founding Date 2017	Founding Date 1998
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare bioengineering biotech genetics nanotech pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech genetics medical devices medical diagnostics platform	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development pharma
Locations	Locations Menlo Park, US HQ	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations Menlo Park, US HQ	Locations Framingham, US HQ	Locations South Plainfield, US HQ
Employees	Employees 1062% decrease	Employees 5,40013% increase	Employees 620	Employees 6	Employees 75448% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 121.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $305.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $1.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods $96.7m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $208.5m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income $7.5m (FY, 2025)	Net income N/A	Net income $682.6m (FY, 2025)
Operating ⚠
Products	Products N/A	Products 6 (FY, 2022)	Products 3 (Feb, 2023)	Products N/A	Products N/A
Funding
Latest funding round	Latest funding round $ 80m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 3m (over 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 82m	Total funding raised $ 2.4m	Total funding raised $ 87.5m	Total funding raised $ 11.2m	Total funding raised N/A